Tucson, AZ, United States of America

Nicole R Congrove

This inventor holds 1 USPTO granted patent. Top assignee: The University of Arizona. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole R Congrove. Retrieved from https://idiyas.com/inventor/nicole-r-congrove

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Nicole R Congrove in Age-Related Macular Degeneration Treatment

Introduction

Nicole R Congrove is an accomplished inventor based in Tucson, AZ. She has made significant contributions to the field of therapeutic compositions aimed at treating age-related macular degeneration (AMD). Her innovative work focuses on methods and systems that enhance the understanding and treatment of this prevalent eye condition.

Latest Patents

Nicole holds a patent for "Methods and systems for screening therapeutic compositions for treating age-related macular degeneration." This invention involves culturing retinal pigment epithelium cells (RPE) and measuring the level of hypoxia-induced exosome release from these cells. The findings can be correlated with the onset and severity of AMD, providing valuable insights for therapeutic interventions.

Career Highlights

Nicole is affiliated with the University of Arizona, where she continues to advance her research in the field of ophthalmology. Her dedication to understanding AMD has positioned her as a key figure in the development of new therapeutic strategies.

Collaborations

Nicole has collaborated with notable colleagues, including Brian S McKay and Anna G Figueroa, to further her research and enhance the impact of her innovations.

Conclusion

Nicole R Congrove's work represents a significant advancement in the treatment of age-related macular degeneration. Her innovative methods and systems have the potential to improve the lives of many individuals affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…